These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 2715653)

  • 1. Epidemiology and control of melanoma in white populations and in Japan.
    Elwood JM
    J Invest Dermatol; 1989 May; 92(5 Suppl):214S-221S. PubMed ID: 2715653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
    Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
    J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nevi and malignant melanoma.
    Crutcher WA; Cohen PJ
    Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.
    Ringborg U; Lagerlöf B; Broberg M; Månsson-Brahme E; Platz A; Thörn M
    Med Oncol Tumor Pharmacother; 1991; 8(3):183-7. PubMed ID: 1803179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
    Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
    J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review.
    Slade J; Salopek TG; Marghoob AA; Kopf AW; Rigel DS
    Recent Results Cancer Res; 1995; 139():87-104. PubMed ID: 7597314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma Epidemiology and Sun Exposure.
    Raimondi S; Suppa M; Gandini S
    Acta Derm Venereol; 2020 Jun; 100(11):adv00136. PubMed ID: 32346751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
    Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
    J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.
    Titus-Ernstoff L; Ernstoff MS; Duray PH; Barnhill RL; Holubkov R; Kirkwood JM
    Epidemiology; 1991 May; 2(3):210-4. PubMed ID: 2054404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Melanoma and its risk factors. Epidemiology and consequences in detection and prevention].
    Bonerandi JJ; Grob JJ
    Ann Dermatol Venereol; 1989; 116(5):411-7. PubMed ID: 2675737
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
    Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
    J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
    Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
    JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy diagnoses of clinically atypical pigmented lesions of the head and neck in adults.
    Udovenko O; Griffin JR; Elston DM
    Am J Dermatopathol; 2014 Oct; 36(10):829-31. PubMed ID: 25247672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplastic nevi are a risk factor for uveal melanoma.
    Hammer H; Oláh J; Tóth-Molnár E
    Eur J Ophthalmol; 1996; 6(4):472-4. PubMed ID: 8997595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.
    Roush GC; Nordlund JJ; Forget B; Gruber SB; Kirkwood JM
    Prev Med; 1988 May; 17(3):273-9. PubMed ID: 3405984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.